Zobrazeno 1 - 9
of 9
pro vyhledávání: '"D. A. Kaperko"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 8, Iss 1, Pp 9-22 (2020)
The introduction into clinical practice of immune checkpoint inhibitors that block cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein-1 (PD-1), and programmed cell death ligand-1 (PD-L1), has improved the prognosis of
Externí odkaz:
https://doaj.org/article/11e329a083234c8a9f618ff122d1c4d5
Autor:
A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir
Publikováno v:
Безопасность и риск фармакотерапии, Vol 7, Iss 3, Pp 120-126 (2019)
In the 1960s, following the Thalidomide Disaster, the World Health Organization (WHO) initiated the development of an international drug safety monitoring programme. The objectives of this WHO programme are to improve the quality and safety of pharma
Externí odkaz:
https://doaj.org/article/b6d8dc91215348808819a2a332b5cf2d
Autor:
E. V. Shubnikova, M. A. Darmostukova, T. M. Bukatina, D. A. Kaperko, N. Y. Velts, A. S. Kazakov, I. I. Snegireva, E. O. Zhuravleva, G. V. Kutekhova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 7, Iss 1, Pp 15-22 (2019)
Efficacy, safety and biotransformation features of any drug are fully revealed during widely using. Therefore, postmarketing studies of the pharmacological properties of drugs are an integral component of pharmacovigilance. The aim of this study was
Externí odkaz:
https://doaj.org/article/ead6ce398a844ead958f84405376efe9
Autor:
S. L. Morokhina, R. N. Alyautdin, D. A. Kaperko, E. V. Shubnikova, I. I. Snegireva, Yu. A. Smirnova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 6, Iss 4, Pp 162-173 (2018)
Abstract. Valerianа officinalis rhizomes whis roots, monocomponent and complex herbal drugs based on Valerianа officinalis, and the drug Corvalol containing chemically synthesized α-bromizovalerianic acid ethyl ester (ethyl bromovalerianate) are O
Externí odkaz:
https://doaj.org/article/e588384a76064beab684ff3431407e00
Autor:
E. V. Shubnikova, T. M. Bukatina, D. A. Kaperko, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, I. I. Snegireva, E. O. Zhuravleva, G. V. Kutekhova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 6, Iss 3, Pp 130-137 (2018)
The monitoring of information on the safety of various drugs is becoming more relevant day by day, as the number of drugs on the pharmaceutical market increases, generic drugs, bio-analogous drugs appear. Long-term post-marketing use of a medicinal p
Externí odkaz:
https://doaj.org/article/63d40362cc72424ebe2f5fd2f527be2d
Autor:
T. V. Romanova, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, I. I. Snegireva, M. A. Darmostukova, D. A. Kaperko, N. Yu. Velts, A. S. Kazakov, E. V. Shubnikova, R. N. Alyautdin
Publikováno v:
Безопасность и риск фармакотерапии, Vol 6, Iss 2, Pp 54-60 (2018)
Diabetes mellitus is the most acute medical and social problem related to the priorities of national health systems. The dramatic and urgent problems of diabetes mellitus are determined by the high prevalence of diabetes, high mortality and early dis
Externí odkaz:
https://doaj.org/article/ab5fcfe354d94ad68882735a6302c03b
Autor:
T. M. Bukatina, E. Yu. Pasternak, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin, A. S. Kazakov, K. E. Zatolochina, I. I. Snegireva, M. A. Darmostukova, E. O. Zhuravleva, T. V. Romanova, N. Yu. Velts, M. L. Maksimov, D. A. Kaperko, G. V. Kutekhova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 5, Iss 3, Pp 133-139 (2018)
Externí odkaz:
https://doaj.org/article/8969d0ff19ac40478f5d5e9db675deb1
Publikováno v:
Безопасность и риск фармакотерапии, Vol 5, Iss 3, Pp 100-103 (2018)
Sodium glucose co-transporter type 2 inhibitors (SGLT2) are a new effective group of oral hypoglygemic drugs for the treatment of diabetes type 2. At the moment there is no unanimous opinion on their safety. The article presents the data on clinical
Externí odkaz:
https://doaj.org/article/7337b07a642740a590dee402af807061
Autor:
M A, Pinigin, Iu N, Mol'kov, V I, Nemyria, O V, Budarina, A A, Safiullin, A V, Ul'ianova, O Iu, Ponomareva, A V, Tsukanov, D A, Kaperko, D N, Osadchuk
Publikováno v:
Gigiena i sanitariia. (5)
The investigators studied the impact of biological air contamination by the dusts resulting from protein feedstuff manufacture and grain on local immunity of the mucosae in children and adults living in the areas that were differently distant from in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ad8a55f01948583f773b6e643b4dc5e
https://pubmed.ncbi.nlm.nih.gov/21341495
https://pubmed.ncbi.nlm.nih.gov/21341495